
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-563-6876
Dr. Tang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
 - Connect with colleagues in the same hospital or clinic.
 - Read the latest clinical news, personalized to your specialty.
 
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2013 - 2017
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2012 - 2013
Stanford University School of MedicineClass of 2012
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2027
TN State Medical License 2023 - 2027
WA State Medical License 2023 - 2027
GA State Medical License 2023 - 2026
LA State Medical License 2023 - 2026
MS State Medical License 2023 - 2026
American Board of Radiology Radiation Oncology- Join now to see all
 
Clinical Trials
- MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial Start of enrollment: 2020 Aug 19
 - Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma Start of enrollment: 2018 Jun 14
Roles: Contact, Principal Investigator
 - Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer Start of enrollment: 2019 Nov 20
Roles: Contact, Principal Investigator
 - Join now to see all
 
Publications & Presentations
PubMed
- 1 citationsContinuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial.Alexander D Sherry, Bilal A Siddiqui, Cara Haymaker, Bryan M Fellman, Marina N Medina-Rosales
European Urology. 2025-11-01 - Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank.Daniel D Shapiro, Edwin Jason Abel, Laurence Albiges, Dena Battle, Stephanie A Berg
Urologic Oncology. 2025-11-01 - Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer.Xiaolei Shi, Jarey H Wang, Brian F Chapin, Ana Aparicio, Sumit K Subudhi
Prostate Cancer and Prostatic Diseases. 2025-10-11 
Press Mentions
Bladder Cancer Trial “Knocked It Out of the Park,” Expert SaysOctober 1st, 2025
Lutetium-177 with RT Prolongs Survival in Prostate CancerOctober 1st, 2025
Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual MeetingApril 25th, 2025- Join now to see all
 
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:












